Holdings

台灣浩鼎生技股份有限公司

As of Oct 31, 2026, 台灣浩鼎生技股份有限公司 reported 2 positions. Largest: Obigen Pharma, Inc., AP Biosciences, Inc. and AP Biosciences, Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Obigen Pharma, Inc.53Mno changeOct 31, 2026
AP Biosciences, Inc.23.2Mno changeOct 31, 2026
AP Biosciences, Inc.no changeNov 22, 2026